Document And Entity Information - USD ($) |
12 Months Ended | ||
|---|---|---|---|
Aug. 31, 2019 |
Dec. 11, 2019 |
Feb. 28, 2019 |
|
| Document And Entity Information [Abstract] | |||
| Entity Registrant Name | ARTELO BIOSCIENCES, INC. | ||
| Entity Central Index Key | 0001621221 | ||
| Entity Current Reporting Status | Yes | ||
| Entity Voluntary Filers | No | ||
| Current Fiscal Year End Date | --08-31 | ||
| Entity Filer Category | Non-accelerated Filer | ||
| Entity Well-known Seasoned Issuer | No | ||
| Entity Common Stock, Shares Outstanding | 3,420,026 | ||
| Entity Public Float | $ 12,811,969 | ||
| Document Type | 10-K/A | ||
| Document Period End Date | Aug. 31, 2019 | ||
| Amendment Flag | true | ||
| Amendment Description | Artelo Biosciences, Inc. (the "Company") is filing this Amendment No. 1 on Form 10-K/A (this "Amendment") to its Annual Report on Form 10-K for the period ended August 31, 2019, which was originally filed on November 25, 2019 (the "Original Filing"). The purpose of this Amendment is to amend and restate Part III.The Company does not anticipate filing its definitive proxy statement within 120 days of its fiscal year ended August 31, 2019. Therefore, the information required by Part III of Form 10-K will not be incorporated by reference to our definitive proxy statement for the 2020 Annual Meeting of Stockholders. Except as described above, this Amendment does not modify or update the disclosure in, or exhibits to, the Original Filing in any way, and the parts or exhibits of the Original Filing which have not been modified or updated are not included in this Amendment. Furthermore, this Form 10-K/A does not change any previously reported financial results, nor does it reflect events occurring after the filing date of the Original Filing. Information not affected by this Form 10-K/A remains unchanged and reflects the disclosures made at the time the Original Filing was filed. This Amendment continues to speak as of the date of the Original Filing and the Company has not updated the disclosure contained herein to reflect events that have occurred since the filing of the Original Filing. Accordingly, this Amendment should be read in conjunction with the Company's other filings made with the Securities and Exchange Commission since the filing of the Original Filing, including amendments to those filings, if any. | ||
| Document Fiscal Year Focus | 2019 | ||
| Document Fiscal Period Focus | FY | ||
| Entity Small Business | true | ||
| Entity Emerging Growth Company | true | ||
| Entity Ex Transition Period | false | ||
| Entity Shell Company | false |